These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 1632467)

  • 1. Overexpression of p53 protein in basal cell carcinomas of human skin.
    Shea CR; McNutt NS; Volkenandt M; Lugo J; Prioleau PG; Albino AP
    Am J Pathol; 1992 Jul; 141(1):25-9. PubMed ID: 1632467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunophenotypic analysis of the p53 gene in non-melanoma skin cancer and correlation with apoptosis and cell proliferation.
    Stratigos AJ; Kapranos N; Petrakou E; Anastasiadou A; Pagouni A; Christofidou E; Petridis A; Papadopoulos O; Kokka E; Antoniou C; Georgala S; Katsambas AD
    J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):180-6. PubMed ID: 15752287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of p53 protein in actinic keratosis, adjacent, normal-appearing, and non-sun-exposed human skin.
    Einspahr J; Alberts DS; Aickin M; Welch K; Bozzo P; Grogan T; Nelson M
    Cancer Epidemiol Biomarkers Prev; 1997 Aug; 6(8):583-7. PubMed ID: 9264270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation spectra of epidermal p53 clones adjacent to basal cell carcinoma and squamous cell carcinoma.
    Bäckvall H; Strömberg S; Gustafsson A; Asplund A; Sivertsson A; Lundeberg J; Ponten F
    Exp Dermatol; 2004 Oct; 13(10):643-50. PubMed ID: 15447725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of p53 in aggressive and non-aggressive histologic variants of basal cell carcinoma.
    Ansarin H; Daliri M; Soltani-Arabshahi R
    Eur J Dermatol; 2006; 16(5):543-7. PubMed ID: 17101476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous squamous cell carcinoma in human immunodeficiency virus-infected patients. A study of epidemiologic risk factors, human papillomavirus, and p53 expression.
    Maurer TA; Christian KV; Kerschmann RL; Berzin B; Palefsky JM; Payne D; Tyring SK; Berger TG
    Arch Dermatol; 1997 May; 133(5):577-83. PubMed ID: 9158410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human patched (PTCH) mRNA is overexpressed consistently in tumor cells of both familial and sporadic basal cell carcinoma.
    Undén AB; Zaphiropoulos PG; Bruce K; Toftgård R; Ståhle-Bäckdahl M
    Cancer Res; 1997 Jun; 57(12):2336-40. PubMed ID: 9192803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Divergence between the high rate of p53 mutations in skin carcinomas and the low prevalence of anti-p53 antibodies.
    Moch C; Moysan A; Lubin R; de la Salmonière P; Soufir N; Galisson F; Vilmer C; Venutolo E; Le Pelletier F; Janin A; Basset-Séguin N
    Br J Cancer; 2001 Dec; 85(12):1883-6. PubMed ID: 11747330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomas.
    Bolshakov S; Walker CM; Strom SS; Selvan MS; Clayman GL; El-Naggar A; Lippman SM; Kripke ML; Ananthaswamy HN
    Clin Cancer Res; 2003 Jan; 9(1):228-34. PubMed ID: 12538474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinogen-specific mutation pattern in the p53 tumour suppressor gene in UV radiation-induced basal cell carcinoma.
    Weihrauch M; Bader M; Lehnert G; Wittekind C; Tannapfel A; Wrbitzky R
    Int Arch Occup Environ Health; 2002 Apr; 75(4):272-6. PubMed ID: 11981662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational spectrum of p53 gene in arsenic-related skin cancers from the blackfoot disease endemic area of Taiwan.
    Hsu CH; Yang SA; Wang JY; Yu HS; Lin SR
    Br J Cancer; 1999 Jun; 80(7):1080-6. PubMed ID: 10362120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analyses of the tumour suppressor ING1 expression and gene mutation in human basal cell carcinoma.
    Chen B; Campos EI; Crawford R; Martinka M; Li G
    Int J Oncol; 2003 Apr; 22(4):927-31. PubMed ID: 12632089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation state of tumor-suppressor gene p53 product overexpressed in skin tumors.
    Matsumoto M; Furihata M; Kurabayashi A; Ohtsuki Y
    Oncol Rep; 2004 Nov; 12(5):1039-43. PubMed ID: 15492790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of p53 and 17p allelic loss in colorectal carcinoma.
    Cunningham J; Lust JA; Schaid DJ; Bren GD; Carpenter HA; Rizza E; Kovach JS; Thibodeau SN
    Cancer Res; 1992 Apr; 52(7):1974-80. PubMed ID: 1551126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Have p53 gene mutations and protein expression a different biological significance in colorectal cancer?
    Bazan V; Migliavacca M; Tubiolo C; Macaluso M; Zanna I; Corsale S; Amato A; Calò V; Dardanoni G; Morello V; La Farina M; Albanese I; Tomasino RM; Gebbia N; Russo A
    J Cell Physiol; 2002 May; 191(2):237-46. PubMed ID: 12064467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. bcl-2 vs p53 protein expression and apoptotic rate in human nonmelanoma skin cancers.
    Wikonkal NM; Berg RJ; van Haselen CW; Horkay I; Remenyik E; Begany A; Hunyadi J; van Vloten WA; de Gruijl FR
    Arch Dermatol; 1997 May; 133(5):599-602. PubMed ID: 9158413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunomorphological features of cutaneous basal-cell carcinoma].
    Chuprov IN
    Vopr Onkol; 2008; 54(6):715-9. PubMed ID: 19241845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infrequent p53 mutations in arsenic-related skin lesions.
    Castrén K; Ranki A; Welsh JA; Vähäkangas KH
    Oncol Res; 1998; 10(9):475-82. PubMed ID: 10223623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
    Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
    Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of p53 protein is common in premalignant head and neck lesions.
    Pavelic ZP; Li YQ; Stambrook PJ; McDonald JS; Munck-Wikland E; Pavelic K; Dacic S; Danilovic Z; Pavelic L; Mugge RE
    Anticancer Res; 1994; 14(5B):2259-66. PubMed ID: 7840533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.